The Obesity Drug That Rivals Surgery In the TRIUMPH-4 trial, retatrutide helped people with obesity lose an average of: 23.7% of their body weight when counting all participants, including those who discontinued treatment 28.7% weight loss among people who stayed on the highest dose throughout the 68-week study Dr Caroline Apovian from Brigham and Womens Hospital called the results incredible, noting that this is the first drug to show weight loss comparable to weight-loss surgery
Insert the needle straight into your skin at a 90-degree angle, press the dose button until it reaches 0, and slowly count to six before you remove the needle
Even though retatrutide isnt an energy-boosting medication, some patients report higher energy levels after weight reduction and more consistent blood sugar levels
When individuals on these medications view images of alcoholic beverages or alcohol-related scenarios, their brains show less activation in areas associated with craving and motivation than placebo-treated controls
Participants began losing weight by the four-week mark, and this trend continued throughout the study period
J Clin Endocrinol Metab 106(2):388396
